Clinical Trials Sponsored by Incozen Therapeutics Pvt Ltd

Total 4 results

Rhizen Pharmaceuticals SA
Incozen Therapeutics Pvt Ltd

Recruiting

Efficacy and Safety of Tenalisib in Patients With Metastatic Triple Negative Breast Cancer (TNBC)

Triple Negative Breast Cancer (TNBC)

India
Rhizen Pharmaceuticals SA
Incozen Therapeutics Pvt Ltd

Completed

Study to Evaluate the Efficacy and Safety of Oral RP7214, a DHODH Inhibitor, in Patients With Symptomatic Mild COVID-19 Infection.

SARS-CoV-2 Infection

India
OcuCure Therapeutics, Inc.
Semler Research Center Pvt. Ltd.

Terminated

A Study Assessing Efficacy and Safety of OC-10X in the Treatment of PDR

Proliferative Diabetic Retinopathy (PDR)

Bangladesh
BioSync Scientific Pvt. Ltd.
Cardialysis BV; MIV Therapeutics Inc.

Unknown

Hydroxyapatite Active Pro Healing Clinical Trial Program (HApFIM)

Coronary Artery Disease

3

Subscribe